HRES93-119

Passed House

Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

119th Congress Introduced Feb 4, 2025

Summary

What This Bill Does

This special rule moves H.R. 27, a fentanyl-related substances bill, to House floor consideration. This is a special House rule, not final enactment of the underlying policies. Its effect is to decide how the House may consider the named measures: it waives points of order, treats measures as read, sets debate time, identifies adopted committee or Rules Committee text, and preserves only the motions listed in the rule. The measures covered are H.R. 27 amending the Controlled Substances Act with respect to the scheduling of fentanyl-related substances. That procedural design matters because it can move controversial disapproval resolutions or policy bills to a final vote while limiting the ability to raise procedural objections or offer amendments.

Who Benefits and How

Supporters of permanent or tighter fentanyl-related substance scheduling, drug enforcement agencies, prosecutors, and public-safety officials benefit from a protected path to a House vote. House majority leadership benefits because the rule converts the covered measures into a controlled floor package. The House Rules Committee benefits because its report and special-rule language define the operative text and amendment process. Committee chairs benefit when they control debate time for their committee's measures. Supporters of the underlying resolutions or bills benefit because the waiver and previous-question language reduce procedural friction.

Who Bears the Burden and How

Defendants affected by fentanyl-related substance scheduling, criminal-justice reform advocates concerned about penalties, Members seeking open amendments, and opponents of H.R. 27 bear procedural burdens. House Members seeking amendments bear a burden because amendments are barred or limited to the Rules Committee report. House minority leadership bears a burden because debate time is capped and the previous question prevents intervening motions except those named in the rule. Opponents of the covered measures lose some procedural tools because points of order against consideration and against provisions are waived. The House Clerk and floor staff must implement the timing, reading, amendment, and message instructions.

Key Provisions

  • Provides consideration of H.R. 27 on fentanyl-related substances.
  • Waives points of order against consideration and provisions in the bill.
  • Provides the Rules Committee amendment structure for floor debate.
  • Limits debate and amendment options under the special rule.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Sets House floor procedures for H.R. 27, a bill amending the Controlled Substances Act with respect to scheduling fentanyl-related substances.

Key Policy Areas

Government, Public Safety, Healthcare

Primary Purpose

Sets House floor procedures for H.R. 27, a bill amending the Controlled Substances Act with respect to scheduling fentanyl-related substances.

Policy Domains

Government Public Safety Healthcare

House resolution provisions

Identified Gains
Contextual inference, no direct clause citation
  • House majority leadership
  • Supporters of H.R. 27
  • Drug enforcement agencies
  • Prosecutors
  • Public-safety officials
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: rh

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • House Members seeking floor amendments
  • Defendants affected by fentanyl scheduling
  • Criminal-justice reform advocates
  • Opponents of H.R. 27
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: rh

Contextual inference, no direct clause citation

Legislative Progress

Passed House
Introduced Committee Passed
Feb 5, 2025

Feb 5, 2025 (inferred)

Passed House (inferred from eh version)

Feb 5, 2025

Motion to reconsider laid on the table Agreed to without …

Feb 5, 2025

POSTPONED PROCEEDINGS - At the conclusion of debate on H. …

Feb 5, 2025

DEBATE - The House proceeded with one hour of debate …

Feb 5, 2025

Considered as privileged matter. (consideration: CR H469-478)

Feb 5, 2025

Motion to reconsider laid on the table Agreed to without …

Feb 5, 2025

On agreeing to the resolution Agreed to by recorded vote: …

Feb 5, 2025

Passed/agreed to in House: On agreeing to the resolution Agreed …

Feb 5, 2025

On ordering the previous question Agreed to by the Yeas …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

General Public
9 mentions across 1 clause
-3 negative ?6 uncertain

Drug enforcement agencies, House Clerk, House Members seeking floor amendments

1/1
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Government Public Safety Healthcare
Actor Mappings
"dea"
→ Drug Enforcement Administration

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology